This post was just published on ZYX Buy Change Alert. FOLD plans to submit a new drug application to FDA for the oral precision medicine migalastat for Fabry disease. The stock is jumping on the news. We are not recommending buying FOLD here but it can be part of a basket on
This post was just published on ZYX Buy Change Alert. For us to recommend, a stock must pass at least four of the six screens. We prefer a stock to meet all six screens. Our rigorous criteria has led to enviable performance over a long period of time. We periodically provide intelligence
This post was just published on ZYX Buy Change Alert. For us to recommend, a stock must pass at least four of the six screens. We prefer a stock to meet all six screens. Our rigorous criteria has led to enviable performance over a long period of time. We periodically provide
We are short diabetes stocks with following average sell prices: LLY 35.30, INCY 4.15, ALKS 9.20, AMLN 11.50 and ALXN 37.6 www.thearorareport.com THE ARORA REPORT, Ltd. HOME OF THE UNIQUE ZYX CHANGE METHOD DEDICATED SOLELY TO PROFIT FROM CHANGE BY TRADING AND INVESTING VERIFIABLE PERFORMANCE RECORD Every closed trade since
Based on our analysis of the presentations at American Diabetes Association’s Annual Meeting in New Orleans, we expect the following stocks to move : LLY, AMLN, ALKS, INCY, HALO,ALXN, MRK AND AZN. Data from all of the above companies is positive. We can easily analyze the data, but predicting the